Difficulties and Countermeasures in Hospital Emergency Management for Fast-Lane Treatment of Acute Stroke During the COVID-19 Epidemic Prevention and Control.

Haojun Yang,Zhihong Zhao,Yunfang Chi,Xinhang Hu,Mengqi Zhang,Bo Xiao,Yishu Fan,Tong Wu,Li Feng,Zhuohui Chen,Lan Xiang

doi:10.3389/fneur.2020.604907

Abstract

Background: Coronavirus disease 2019 (COVID-19) has a long incubation period and a high degree of infectivity. Patients may not show specific signs or symptoms of upper respiratory tract infection, and the age of onset is similar to that of stroke. Furthermore, an increase in neurological conditions, specifically acute cerebrovascular disease, has been detected. Providing emergency treatment for acute stroke in accordance with the strict epidemic control measures is currently one of the main challenges, as acute stroke is rapid onset and a major cause of death and disability globally. We aimed to evaluate the emergency treatment system for acute stroke during the epidemic control period to provide a reference and basis for informing government and medical institutions on improving patient treatment rates during this period.Methods: Difficulties faced in providing emergency treatment for stroke during an epidemic were investigated and combined with medical educational resources and clinical management experiences to construct an emergency treatment framework for acute stroke during the epidemic.Findings: Currently, emergency treatment measures for acute stroke during the epidemic control period are limited because the main focus is on identifying COVID-19 comorbidities during the critical period. Establishing standards for patients in the neurological outpatient consultation rooms and emergency observation and resuscitation zones; implementing a fast-lane system for the emergency treatment of patients with acute stroke, and strengthening ward management and medicine popularization, can improve the treatment efficiency for stroke patients during the epidemic and provide a reference for peers in clinical practice.Interpretation: Emergency treatment for acute stroke during COVID-19 epidemic control period requires a joint promotion of clinical, popularization, and teaching resources.

Highlights

In December 2019, an outbreak of a novel coronavirus pneumonia (NCP) occurred in Wuhan, Hubei province, China, and it rapidly spread to different provinces in China, as well as countries in Southeast Asia, Europe, North America, and many others [1]
During the COVID-19 epidemic, identifying patient with comorbid COVID-19 symptoms during the golden hour for acute stroke treatment is a challenge in stroke control
MZ conceptualized the study, acquired funding, and administered the project

Summary

Introduction

In December 2019, an outbreak of a novel coronavirus pneumonia (NCP) occurred in Wuhan, Hubei province, China, and it rapidly spread to different provinces in China, as well as countries in Southeast Asia, Europe, North America, and many others [1]. The main clinical manifestations are respiratory, an increase in neurological conditions, acute cerebrovascular disease, has been detected [9,10,11]. Stroke refers to acute neurological dysfunction due to a vascular cause, which tends to occur mostly in winter and spring and is rapid onset and a major cause of death and disability globally [12, 13]. Providing emergency treatment for acute stroke in accordance with the strict epidemic control measures is currently one of the main challenges, as acute stroke is rapid onset and a major cause of death and disability globally. We aimed to evaluate the emergency treatment system for acute stroke during the epidemic control period to provide a reference and basis for informing government and medical institutions on improving patient treatment rates during this period

Objectives

Results

Conclusion